← SynDRA
SYN1715675
SynDRA canonical compound SYN1715675 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NUDT1 |
|---|
| Mechanism of action | MTH1 inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- TH588
- N4-Cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine
- TH-588
- MFCD28963908
- 4-N-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine
- 6-(2,3-Dichlorophenyl)-N4-cyclopropylpyrimidine-2,4-diamine
- C13H12Cl2N4
- 2GE
- orb1306674
- SCHEMBL15757649
- SCHEMBL26128076
- SCHEMBL29417864
- EX-A650
- PNMYJIOQIAEYQL-UHFFFAOYSA-N
- GLXC-04721
- N4-Cyclopropyl-6-(2,3-dichlorophenyl)-2,4-pyrimidinediamine
- BDBM50152124
- NSC782923
- s7632
- AKOS026750322
- CCG-267417
- CS-4507
- NSC-782923
- TH 588?
- NCGC00384192-02
- NCGC00384192-06
- AC-33078
- AS-16451
- DA-58466
- HY-12814
- TH588; TH-588; TH 588
- F801694
- BRD-K01054709-001-01-3
Look up SYN1715675 in the interactive SynDRA portal →